BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 27593247)

  • 21. Diffusion-weighted and PET/MR Imaging after Radiation Therapy for Malignant Head and Neck Tumors.
    Varoquaux A; Rager O; Dulguerov P; Burkhardt K; Ailianou A; Becker M
    Radiographics; 2015; 35(5):1502-27. PubMed ID: 26252192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Techniques, benefits, and challenges of PET-MR.
    Ocampo T; Knight K; Dunleavy R; Shah SN
    Radiol Technol; 2015; 86(4):393-412; quiz 413-6. PubMed ID: 25835405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Initial experience of MR/PET in a clinical cancer center.
    Partovi S; Robbin MR; Steinbach OC; Kohan A; Rubbert C; Vercher-Conejero JL; Kolthammer JA; Faulhaber P; Paspulati RM; Ros PR
    J Magn Reson Imaging; 2014 Apr; 39(4):768-80. PubMed ID: 24006287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hybrid PET/MR imaging: physics and technical considerations.
    Shah SN; Huang SS
    Abdom Imaging; 2015 Aug; 40(6):1358-65. PubMed ID: 25985965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical PET/MR Imaging in Oncology: Future Perspectives.
    Kjær A; Torigian DA
    PET Clin; 2016 Oct; 11(4):489-93. PubMed ID: 27593252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical evaluation of female pelvic tumors : Application fields of integrated PET/MRI].
    Grueneisen J; Umutlu L
    Radiologe; 2016 Jul; 56(7):605-11. PubMed ID: 27315240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging Molecular Imaging Techniques in Gynecologic Oncology.
    Lin G; Lai CH; Yen TC
    PET Clin; 2018 Apr; 13(2):289-299. PubMed ID: 29482755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [¹⁸F]fluorodeoxyglucose PET/computed tomography in breast cancer and gynecologic cancers: a literature review.
    Hildebrandt MG; Kodahl AR; Teilmann-Jørgensen D; Mogensen O; Jensen PT
    PET Clin; 2015 Jan; 10(1):89-104. PubMed ID: 25455882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast PET/MR Imaging.
    Melsaether A; Moy L
    Radiol Clin North Am; 2017 May; 55(3):579-589. PubMed ID: 28411681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical PET-MR Imaging in Breast Cancer and Lung Cancer.
    Rice SL; Friedman KP
    PET Clin; 2016 Oct; 11(4):387-402. PubMed ID: 27593245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PET/MR - a rapidly growing technique of imaging in oncology and neurology.
    Sałyga A; Guzikowska-Ruszkowska I; Czepczyński R; Ruchała M
    Nucl Med Rev Cent East Eur; 2016; 19(1):37-41. PubMed ID: 26841378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
    Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
    J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PET-MR and SPECT-MR multimodality probes: Development and challenges.
    Yang CT; Ghosh KK; Padmanabhan P; Langer O; Liu J; Eng DNC; Halldin C; Gulyás B
    Theranostics; 2018; 8(22):6210-6232. PubMed ID: 30613293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PET/MR Imaging in Musculoskeletal Disorders.
    Andersen KF; Jensen KE; Loft A
    PET Clin; 2016 Oct; 11(4):453-63. PubMed ID: 27593249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PET/MR imaging of pelvic malignancies.
    Wetter A; Grueneisen J; Umutlu L
    Eur J Radiol; 2017 Sep; 94():A44-A51. PubMed ID: 28262272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of apparent diffusion coefficient with simultaneous MR/positron emission tomography in patients with peritoneal carcinomatosis: comparison with 18F-FDG-PET.
    Schwenzer NF; Schmidt H; Gatidis S; Brendle C; Müller M; Königsrainer I; Claussen CD; Pfannenberg AC; Schraml C
    J Magn Reson Imaging; 2014 Nov; 40(5):1121-8. PubMed ID: 24923481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PET/CT in gynecologic malignancies.
    Brunetti J
    Radiol Clin North Am; 2013 Sep; 51(5):895-911. PubMed ID: 24010912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Role of Computed Tomography and Magnetic Resonance Imaging in Gynecologic Oncology.
    Laifer-Narin SL; Genestine WF; Okechukwu NC; Hecht EM; Newhouse JH
    PET Clin; 2018 Apr; 13(2):127-141. PubMed ID: 29482746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. (18)F-Fluorodeoxyglucose PET/MR Imaging in Lymphoma.
    Platzek I
    PET Clin; 2016 Oct; 11(4):363-73. PubMed ID: 27593243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac Applications of PET/MR Imaging.
    Lau JM; Laforest R; Nensa F; Zheng J; Gropler RJ; Woodard PK
    Magn Reson Imaging Clin N Am; 2017 May; 25(2):325-333. PubMed ID: 28390532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.